Product NDC: | 63304-625 |
Proprietary Name: | Furosemide |
Non Proprietary Name: | Furosemide |
Active Ingredient(s): | 40 mg/1 & nbsp; Furosemide |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 63304-625 |
Labeler Name: | Ranbaxy Pharmaceuticals Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA078010 |
Marketing Category: | ANDA |
Start Marketing Date: | 20090129 |
Package NDC: | 63304-625-01 |
Package Description: | 100 TABLET in 1 BOTTLE (63304-625-01) |
NDC Code | 63304-625-01 |
Proprietary Name | Furosemide |
Package Description | 100 TABLET in 1 BOTTLE (63304-625-01) |
Product NDC | 63304-625 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Furosemide |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20090129 |
Marketing Category Name | ANDA |
Labeler Name | Ranbaxy Pharmaceuticals Inc. |
Substance Name | FUROSEMIDE |
Strength Number | 40 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Increased Diuresis at Loop of Henle [PE],Loop Diuretic [EPC] |